Gamma-interferon treatment for resistant oropharyngeal candidiasis in an HIV-positive patient

被引：19

作者：

Bodasing, N

Seaton, RA

Shankland, GS

Pithie, A

机构：

[1] Gartnavel Royal Hosp, Brownlee Ctr, Glasgow G12 0YN, Lanark, Scotland

[2] Univ Glasgow, Western Infirm, Mycol Reference Lab, Glasgow G11 6NT, Lanark, Scotland

[3] Christchurch Hosp, Christchurch, New Zealand

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2002年 / 50卷 / 05期

关键词：

D O I：

10.1093/jac/dkf206

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：765 / 766

页数：2

共 6 条

[1]

Billiau A, 1996, ADV IMMUNOL, V62, P61, DOI 10.1016/S0065-2776(08)60428-9

[2] Gamma interferon protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis [J].

Fratti, RA ;

Ghannoum, MA ;

Edwards, J ;

Filler, SG .

INFECTION AND IMMUNITY, 1996, 64 (11) :4714-4718

[3] SYNERGIC INHIBITORY ACTIVITY OF AMPHOTERICIN-B AND GAMMA-INTERFERON AGAINST INTRACELLULAR CRYPTOCOCCUS-NEOFORMANS IN MURINE MACROPHAGES [J].

HERRMANN, JL ;

DUBOIS, N ;

FOURGEAUD, M ;

BASSET, D ;

LAGRANGE, PH .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (06) :1051-1058

[4] Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis [J].

Martínez, M ;

López-Ribot, JL ;

Kirkpatrick, WR ;

Bachmann, SP ;

Perea, S ;

Ruesga, MT ;

Patterson, TF .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (03) :515-524

[5] INTERFERON-GAMMA, THE ACTIVATED MACROPHAGE, AND HOST DEFENSE AGAINST MICROBIAL CHALLENGE [J].

MURRAY, HW .

ANNALS OF INTERNAL MEDICINE, 1988, 108 (04) :595-608

[6]

QUINTI I, 1991, CLIN EXP IMMUNOL, V85, P485, DOI 10.1111/j.1365-2249.1991.tb05754.x

← 1 →